Information regarding activities Sample Clauses
The 'Information regarding activities' clause requires one party to provide details about their actions or operations relevant to the agreement. This may include regular updates, reports, or disclosures about ongoing projects, business practices, or compliance with certain standards. By mandating the sharing of such information, the clause ensures transparency between parties and helps prevent misunderstandings or disputes related to undisclosed activities.
Information regarding activities. The Company shall provide to the ▇▇▇ such information relating to its activities as the ▇▇▇ may reasonably require for the purpose of carrying out any of its functions under Part I of the Railways Act other than any information which it could not be compelled to produce or to give in evidence in civil proceedings in any court.
Information regarding activities. On or before January 20 of each year during the Term, ▇▇▇▇▇▇▇ shall provide Genmab’s Alliance Manager with a written report summarising, in reasonable detail, its activities conducted during the preceding Calendar Year with respect to the Development and Commercialisation of each Licensed Product. In addition, ▇▇▇▇▇▇▇ shall provide Genmab’s Alliance Manager within [***] calendar days of the end of each Calendar Quarter during the Term a written update setting out in reasonable detail any such activities not previously reported by ▇▇▇▇▇▇▇ to Genmab pursuant to this Clause and which details have not otherwise been provided to Genmab in writing. It is understood that the minutes of the JSC or Development Committee meetings may serve as written notice under this provision, to the extent that they fully report ▇▇▇▇▇▇▇’▇ Development and Commercialisation activities during the relevant
Information regarding activities. Within fourteen (14) days of the three (3) month anniversary of the Closing, TenX shall provide Genmab with a written report summarizing, in reasonable detail, activities conducted during the prior three (3) months with respect to its, or its sublicensees’, Development and Commercialization of each and any Product and thereafter TenX shall provide Genmab with like reports on a quarterly basis. When the registration package requesting Regulatory Approval for commercial sale of each and any Product is first filed in the U.S., the EU or Japan, and when approval is received therefore, in each case, TenX shall immediately notify Genmab in writing.